Andy Birchfield in the News

Photo of Andy Birchfield Andy D. Birchfield, Jr.
Lead Attorney in $4.85 Billion Vioxx Settlement
 

Articles 61 to 70 of 97 for attorney Andy Birchfield.

Beasley Allen Law Firm Leads National COX-2 Litigation

April 13, 2005

One of the most popular in the COX-2 class, Vioxx - used by tens of millions of people worldwide - was pulled off the market last October. This decision came shortly after medical conference where FDA researcher David Graham showed higher doses of Vioxx correlated with a tripled risk of heart attack or sudden cardiac death compared to people who weren't taking any similar drug.

Merck wants Vioxx Case Dismissed

April 13, 2005

The Vioxx pills that an Alabama widow claims caused her husband's death Sept. 4, 2001, were not on the market until a half year later.

Judge Selects Alabama Lawyer for Federal Vioxx Suits

THE ASSOCIATED PRESS | April 8, 2005

The Federal Vioxx cases took a major step forward on Friday when U.S. District Judge Eldon E. Fallon selected a plaintiffs steering committee that includes an Alabama lawyer as co-lead counsel.

Judge Selects Vioxx Suits Steering Panel

TALLAHASSEE DEMOCRAT | April 8, 2005

The Federal Vioxx cases took a major step forward on Friday when U.S. District Judge Eldon E. Fallon selected a plaintiffs steering committee that includes an Alabama lawyer as co-lead counsel.

Beasley Allen Attorney Andy Birchfield Named Co-lead Counsel for Vioxx lawsuits

April 8, 2005

In a pretrial order issued today, Judge Fallon of the United States District Court in Louisiana appointed Mr. Birchfield of Beasley Allen as co-lead counsel with regard to pending Vioxx products liability litigation.

Judge Selects Vioxx lawsuits Steering Panel

April 8, 2005

The federal Vioxx cases took a major step forward when U.S. District Judge Eldon E. Fallon selected a plaintiffs steering committee that will help shepherd what is expected to be lengthy and complex litigation.

A Drugs Day in Court

AARP BULLETIN | April 7, 2005

Since Merck withdrew its blockbuster painkilling drug Vioxx from the market last September, saying it increased the risk of heart attacks and strokes, the company has been deluged by lawsuits. One law firm alone, alone, among hundreds across the nation handling Vioxx cases, has received more than 10,000 inquiries from the drug.

Beasley Allen Believes Bextra Recall was Long Overdue

April 7, 2005

Pfizer (the manufacturer of Celebrex and Bextra) suspended sales of their arthritis drug, Bextra, following a recommendation from the Food and Drug Administration (FDA). Unfortunately, this move may have come too late for thousands of people that have suffered a heart attack or stroke while taking this medication.

Vioxx Watch: Mass Tort Manager, The Next Big MDL Takes Two Steps Forward

THE AMERICAN LAWYER | April 1, 2005

Mardi Gras is over, and the college kids on spring break have left New Orleans. But the Big Easy can rest assured: The Vioxx bar has taken their place.

Vioxx Watch: The next big MDL takes two Steps Forward

April 1, 2005

Judicial Panel on Multi-district Litigation sent pending product liability litigation involving Merck & Co., Inc.'s Vioxx drug to Judge Eldon Fallon of the Eastern District of Louisiana.